Literature DB >> 6994684

Metabolic activation of 2-acetylaminofluorene by isolated rat liver cells. Involvement of different metabolites causing DNA-repair and bacterial mutagenesis.

R M Brouns, R P Bos, R von Doorn, P T Henderson.   

Abstract

Isolated rat liver cells are able to metabolize 2-acetylaminofluorene (2-AAF) to reactive species, capable of producing mutagenic effects in Salmonella typhimurium TA 1518 and evoking unscheduled DNA synthesis within the hepatocytes. Indications are presented, that these genotoxic effects are caused by different reactive metabolites. Mutagenesis could be blocked almost completely by paraoxon, an inhibitor of the de-acetylation reaction, whereas induction of DNA excision repair was prevented by antagonizing the sulfation reaction by means of salicylamide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994684     DOI: 10.1007/bf00303295

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  17 in total

Review 1.  Interaction of chemical carcinogens and drug-metabolizing enzymes in primary cultures of hepatic cells from the rat.

Authors:  G Michalopoulos; G Sattler; C Sattler; H C Pitot
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

2.  Conjugation of various drugs in isolated hepatocytes.

Authors:  B Andersson; M Berggren; P Moldéus
Journal:  Drug Metab Dispos       Date:  1978 Nov-Dec       Impact factor: 3.922

3.  Mutagenic effects of benzo[a]pyrene after metabolic activation by hepatic 9000 g supernatants or intact hepatocytes.

Authors:  R E Brouns; R P Bos; P J van Gemert; E W Yih-van de Hurk; P T Henderson
Journal:  Mutat Res       Date:  1979-08       Impact factor: 2.433

4.  N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver.

Authors:  J R DeBaun; E C Miller; J A Miller
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

5.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

6.  Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures.

Authors:  G M Williams
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

7.  Studies on the mutagenicity of N-hydroxy-2-acetylaminofluorene in the Ames-Salmonella mutagenesis test system.

Authors:  L S Andrews; J A Hinson; J R Gillette
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

Review 8.  Hepatocyte suspensions and cultures as tools in experimental carcinogenesis.

Authors:  P O Seglen
Journal:  J Toxicol Environ Health       Date:  1979 Mar-May

9.  Differential effect of a microsomal deacetylase inhibition on the mutagenicity in Salmonella typhimurium of 2-acetylaminofluorene by liver homogenates of guinea pigs, mice and rats.

Authors:  S Okuno; K Takeishi; T Seno
Journal:  Cancer Lett       Date:  1979-01       Impact factor: 8.679

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  3 in total

1.  Sex differences in the biotransformation of 2-acetylaminofluorene in cultured rat hepatocytes.

Authors:  C A McQueen; M J Miller; G M Williams
Journal:  Cell Biol Toxicol       Date:  1986-06       Impact factor: 6.691

2.  Effects of vitamin A on the metabolism and mutagenicity of 2AAF in vitro and on the covalent binding to rat liver DNA/RNA in vivo.

Authors:  L Rondahl; L Busk; U G Ahlborg; K Bergman
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

3.  Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetyl-aminofluorene mutagenesis in the Salmonella/microsome assay.

Authors:  L Busk; U G Ahlborg
Journal:  Arch Toxicol       Date:  1982-01       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.